Garreta A;Val-Moraes SP;García-Fernández Q;Busquets M;Juan C;Oliver A; Ortiz A;Gaffney BJ;Fita I;Manresa À;Carpena X, "Structure and interaction with phospholipids of a prokaryotic lipoxygenase from Pseudomonas aeruginosa", "Faseb Journal", Volum 27, Número 12, Pàgines 4811-4821, 2013. Article.
Mondon M;Hur S;Vadlamani G;Rodrigues P;Tsybina P;Oliver A;Mark BL; Vocadlo DJ;Blériot Y, "Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams", "Chemical Communications", Volum 49, Número 93, Pàgines 10983-10985, 2013. Article.
Mulet X;Cabot G;Ocampo-Sosa AA;Domínguez MA;Zamorano L;Juan C;Tubau F; Rodríguez C;Moyà B;Peña C;Martínez-Martínez L;Oliver A, "Biological markers of Pseudomonas aeruginosa epidemic high-risk clones", "Antimicrobial Agents and Chemotherapy", Volum 57, Número 11, Pàgines 5527-5535, 2013. Article.
Vatcheva-Dobrevska R;Mulet X;Ivanov I;Zamorano L;Dobreva E;Velinov T; Kantardjiev T;Oliver A, "Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals", "Microbial Drug Resistance", Volum 19, Número 5, Pàgines 355-361, 2013. Article.
Pérez-Llarena FJ;Kerff F;Zamorano L;Fernández MC;Nuñez ML;Miró E;Oliver A;Navarro F;Bou G, "Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 loop that affects ceftazidime hydrolysis", "Antimicrobial Agents and Chemotherapy", Volum 57, Número 10, Pàgines 5158-5161, 2013. Article.
Gilarranz R;Juan C;Castillo-Vera J;Chamizo FJ;Artiles F;Álamo I;Oliver A, "First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa", "Clinical Microbiology and Infection", Volum 19, Número 9, Pàgines E424-E427, 2013. Article.
López-Causapé C;Rojo-Molinero E;Mulet X;Cabot G;Moyà B;Figuerola J; Togores B;Pérez JL;Oliver A, "Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection", "Plos One", Volum 8, Número 8, Pàgines e71001, 2013. Article.
Peña C;Suarez C;Ocampo-Sosa A;Murillas J;Almirante B;Pomar V;Aguilar M;Granados A;Calbo E;Rodríguez-Baño J;Rodríguez F;Tubau F;Oliver A; Martínez-Martínez L, "Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort", "Clinical Infectious Diseases", Volum 57, Número 2, Pàgines 208-216, 2013. Article.
Rodríguez-Baño J;Oteo J;Ortega A;Villar M;Conejo MC;Bou G; Aranzamendi-Zaldumbide M;Cercenado E;Gurguí M;Martínez-Martínez L;Merino M;Rivera A;Oliver A;Weber I;Pascual A;Bartolomé RM;Gónzalez-López JJ;Campos J, "Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli", "Journal of Clinical Microbiology", Volum 51, Número 7, Pàgines 2414-2417, 2013. Article.
Weber I;Riera E;Déniz C;Pérez JL;Oliver A;Mena A, "Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain", "International Journal of Medical Microbiology", Volum 303, Número 3, Pàgines 128-133, 2013. Article.
Juan C;Conejo MC;Tormo N;Gimeno C;Pascual Á;Oliver A, "Challenges for accurate susceptibility testing;detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study", "Journal of Antimicrobial Chemotherapy", Volum 68, Número 3, Pàgines 619-630, 2013. Article.
Hengzhuang W;Ciofu O;Yang L;Wu H;Song Z;Oliver A;Høiby N, "High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms", "Antimicrobial Agents and Chemotherapy", Volum 57, Número 1, Pàgines 196-204, 2013. Article.